Aspira Women’s Health Inc. (NASDAQ:AWH) Sees Large Decline in Short Interest

Aspira Women’s Health Inc. (NASDAQ:AWH) saw a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 971,900 shares, a decrease of 35.6% from the February 28th total of 1,510,000 shares. Based on an average daily trading volume, of 4,090,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 7.7% of the shares of the company are short sold.

Institutional Trading of Aspira Women’s Health

A hedge fund recently bought a new stake in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co purchased a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) in the third quarter, according to its most recent filing with the SEC. The firm purchased 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned 0.19% of Aspira Women’s Health at the end of the most recent quarter. 12.19% of the stock is owned by institutional investors and hedge funds.

Aspira Women’s Health Trading Down 4.4 %

Shares of AWH stock opened at $0.11 on Friday. Aspira Women’s Health has a 12-month low of $0.08 and a 12-month high of $3.63. The company has a market cap of $1.86 million, a price-to-earnings ratio of -0.09 and a beta of 1.57. The stock has a 50 day simple moving average of $0.25 and a 200-day simple moving average of $0.60.

Aspira Women’s Health (NASDAQ:AWH) last released its quarterly earnings data on Thursday, March 27th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.13. The business had revenue of $2.35 million during the quarter, compared to analysts’ expectations of $3.00 million.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Aspira Women’s Health in a report on Sunday, January 12th. They issued a “hold” rating on the stock.

Aspira Women’s Health Company Profile

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.